- Cell2B was incorporated in January 2011 with the goal of developing a new set of therapies to treat conditions that so far didn’t have any effective treatments in the market.
- Cell2B is the result of the founders’ graduate work and is the step towards the clinical application of the promising results achieved. Cell2B is a spin-off from the Stem Cell Bioengineering Laboratory at Instituto Superior Técnico, Portugal.
History